RUBY - Rubius Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

-11.92M

Cash

14.87M

Avg Qtr Burn

-37.54M

Short % of Float

3.88%

Insider Ownership

5.50%

Institutional Own.

53.69%

Qtr Updated

12/31/22

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
RTX-321 \| HPV peptide antigen expression Details Solid tumor/s, Cancer, Human papillomavirus	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RTX-224 \| 4-1BBL and IL-12 expression Details Solid tumor/s, Cancer	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
RTX-240 \| 4-1BBL & IL-15TP expression Details Solid tumor/s, Cancer, Non-small cell lung carcinoma, Renal cell carcinoma	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.